SC
AGN

Scotia Capital’s Allergan plc AGN Stock Holding History

Scotia Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-28,825
Closed -$5.11M – 741
2020
Q1 		$5.11M Buy
28,825
+297
+1% +$55.9K 0.07% 152
2019
Q4 		$5.46M Sell
28,528
-1,822
-6% -$329K 0.06% 168
2019
Q3 		$5.11M Sell
30,350
-321
-1% -$52.3K 0.06% 163
2019
Q2 		$5.14M Buy
30,671
+2,433
+9% +$337K 0.06% 161
2019
Q1 		$4.13M Sell
28,238
-1,589
-5% -$230K 0.05% 189
2018
Q4 		$3.99M Sell
29,827
-133
-0.4% -$21.8K 0.06% 183
2018
Q3 		$5.71M Sell
29,960
-2,150
-7% -$395K 0.07% 162
2018
Q2 		$5.37M Sell
32,110
-521
-2% -$83.6K 0.07% 158
2018
Q1 		$5.49M Buy
32,631
+17,256
+112% +$2.89M 0.08% 156
2017
Q4 		$2.52M Sell
15,375
-7,002
-31% -$1.26M 0.03% 264
2017
Q3 		$4.58M Buy
22,377
+8,095
+57% +$1.88M 0.07% 170
2017
Q2 		$3.47M Sell
14,282
-48
-0.3% -$11.3K 0.06% 183
2017
Q1 		$3.43M Sell
14,330
-16,419
-53% -$3.82M 0.06% 199
2016
Q4 		$6.46M Buy
30,749
+4,997
+19% +$1.04M 0.1% 140
2016
Q3 		$5.93M Sell
25,752
-122
-0.5% -$29.8K 0.11% 141
2016
Q2 		$5.99M Buy
+25,874
New +$5.97M 0.12% 125
2016
Q1 		– Sell
-11,439
Closed -$3.58M – 890
2015
Q4 		$3.58M Hold
11,439
– – 0.08% 183
2015
Q3 		$3.11M Buy
11,439
+861
+8% +$264K 0.07% 195
2015
Q2 		$3.15M Buy
10,578
+4,010
+61% +$1.2M 0.06% 214
2015
Q1 		$1.96M Buy
6,568
+3,678
+127% +$1.05M 0.05% 228
2014
Q4 		$744K Buy
+2,890
New +$722K 0.02% 350
2014
Q3 		– Sell
-2,394
Closed -$534K – 629
2014
Q2 		$534K Buy
2,394
+175
+8% +$36.2K 0.01% 394
2014
Q1 		$457K Buy
2,219
+14
+0.6% +$2.77K 0.01% 413
2013
Q4 		$370K Buy
2,205
+550
+33% +$86K 0.01% 425
2013
Q3 		$238K Buy
+1,655
New +$220K 0.01% 438

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Scotia Capital's AGN Position: Q2 2020 in Review

Scotia Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 28,825 shares — an estimated $5.11M sold.

Scotia Capital first reported a position in AGN in Q3 2013 and held it in 25 quarters. The position peaked at $6.46M in Q4 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Scotia Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Scotia Capital sold 28,825 Allergan plc shares in Q2 2020, an estimated $5.11M.
  • Scotia Capital first reported a position in Allergan plc in Q3 2013 and held it in 25 quarters.
  • Scotia Capital's Allergan plc position peaked at $6.46M in Q4 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Scotia Capital's 13F filing for Q2 2020, filed 11 Aug 2020.